New GlaxoSmithKline CEO prepares for R&D choices, potential deals
Go back to New GlaxoSmithKline CEO prepares for R&D choices, potential deals| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 2,071 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 125.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $125.05 | 52 Week High | $108.63 | |||
| Open | $125.05 | 52 Week Low | $71.39 | |||
| Day High | $125.05 | P/E | 69.09 | |||
| Day Low | $125.05 | EPS | $1.81 | |||
| Volume | 1,577 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 52.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.07 | 52 Week High | $45.58 | |||
| Open | $52.07 | 52 Week Low | $37.82 | |||
| Day High | $52.07 | P/E | N/A | |||
| Day Low | $52.07 | EPS | $0.00 | |||
| Volume | 3,640 | |||||
| NOVEN PHARMACEUTIC (NASDAQ: NOVN) | Delayed: 0.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.09 | 52 Week High | $23.79 | |||
| Open | $10.12 | 52 Week Low | $13.73 | |||
| Day High | $0.09 | P/E | 0.09 | |||
| Day Low | $0.09 | EPS | $1.05 | |||
| Volume | 1,574,031 | |||||

